Diagnosis and Response to Treatment Using a Reliable Gastroesophageal Reflux Disease (GERD) Questionnaire: An In Clinical Practice Study
GQS
1 other identifier
observational
250
1 country
2
Brief Summary
The purpose of the study is to determine the applicability and utility of Gerd Q in the diagnosis of GERD and in the assessment of treatment response.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2009
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 12, 2009
CompletedFirst Posted
Study publicly available on registry
August 21, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2009
CompletedOctober 21, 2010
October 1, 2010
4 months
August 12, 2009
October 20, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine the applicability and utility of Gerd Q in the diagnosis of GERD and assessment of treatment response
The applicability and utility of the Gerd Questionnaire will be done on 2 vists- Day 1 and Day 30
Secondary Outcomes (1)
To assess and monitor the treatment response of patients diagnosed with GERD
The monitoring and assessment of treatment response using the Gerd Questionnaire will be done on 2 vists-Day 1 and Day 30
Eligibility Criteria
Primary care clinic
You may qualify if:
- Patients of either gender aged between 18-79 years of age
- Patients must be having symptoms of gastroesophageal reflux disease
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (2)
Research Site
Kuala Lumpur, Malaysia
Research Site
Kuala Selangor, Malaysia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Goh Khean Lee, MBBS, MRCP, FRCP
Faculty of Medicine, University of Malaya Medical Center (UMMC),
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
August 12, 2009
First Posted
August 21, 2009
Study Start
July 1, 2009
Primary Completion
November 1, 2009
Study Completion
November 1, 2009
Last Updated
October 21, 2010
Record last verified: 2010-10